Top

ADHD Attention Deficit and Hyperactivity Disorders

Published in:

01-12-2018 | Case Report

ADHD symptoms in a young patient with central diabetes insipidus

Authors: Irene Dupong, Sophie Guilmin-Crepon, Peyre Hugo

Published in: ADHD Attention Deficit and Hyperactivity Disorders | Issue 4/2018

Abstract

Diabetes insipidus is known to be associated with neurodevelopmental disorders. In this case report, we present a child suffering from a central diabetes insipidus (DI) and an attention-deficit/hyperactivity disorder (ADHD). The DI was due to a mutation on the vasopressin gene, impairing its secretion. We discuss the effects of this impairment on the central nervous system and how it might be linked to ADHD symptoms.

American Psychiatric Association, American Psychiatric Association (ed) (2013) Diagnostic and statistical manual of mental disorders: DSM-5, 5th edn. American Psychiatric Association, Washington, DC

Bilgiç A, Toker A, Uysal S (2016) Exploratory study to evaluate plasma vasopressin and apelin-13 levels in children with attention-deficit hyperactivity disorder. Psychiatry Clin Neurosci 70:442–447. https://doi.org/10.1111/pcn.12415 CrossRefPubMed

Blum K, Chen AL-C, Braverman ER et al (2008) Attention-deficit-hyperactivity disorder and reward deficiency syndrome. Neuropsychiatr Dis Treat 4:893–918PubMedPubMedCentral

Born J, Pietrowsky R, Fehm HL (1998) Neuropsychological effects of vasopressin in healthy humans. Prog Brain Res 119:619–643CrossRef

Brook CGD, Clayton PE, Brown RS, Wiley InterScience (Online service) (2009) Brook’s clinical pediatric endocrinology. Wiley-Blackwell, Hoboken

Bruins J, Kovács GL, Abbes AP et al (2006) Minor disturbances in central nervous system function in familial neurohypophysial diabetes insipidus. Psychoneuroendocrinology 31:80–91. https://doi.org/10.1016/j.psyneuen.2005.06.001 CrossRefPubMed

de Wied D, Diamant M, Fodor M (1993) Central nervous system effects of the neurohypophyseal hormones and related peptides. Front Neuroendocrinol 14:251–302. https://doi.org/10.1006/frne.1993.1009 CrossRefPubMed

DuPaul GJ (ed) (1998) ADHD rating scale-IV: checklists, norms, and clinical interpretation. Guilford Press, New York

Ebstein RP, Knafo A, Mankuta D et al (2012) The contributions of oxytocin and vasopressin pathway genes to human behavior. Horm Behav 61:359–379. https://doi.org/10.1016/j.yhbeh.2011.12.014 CrossRef

Egashira N, Tanoue A, Higashihara F et al (2004) V1a receptor knockout mice exhibit impairment of spatial memory in an eight-arm radial maze. Neurosci Lett 356:195–198. https://doi.org/10.1016/j.neulet.2003.11.050 CrossRefPubMed

Engelmann M, Landgraf R (1994) Microdialysis administration of vasopressin into the septum improves social recognition in Brattleboro rats. Physiol Behav 55:145–149CrossRef

Faraone SV, Perlis RH, Doyle AE et al (2005) Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1313–1323. https://doi.org/10.1016/j.biopsych.2004.11.024 CrossRefPubMed

Frank E, Landgraf R (2008) The vasopressin system—from antidiuresis to psychopathology. Eur J Pharmacol 583:226–242. https://doi.org/10.1016/j.ejphar.2007.11.063 CrossRefPubMed

Hammock EAD, Young LJ (2006) Oxytocin, vasopressin and pair bonding: implications for autism. Philos Trans R Soc Lond B Biol Sci 361:2187–2198. https://doi.org/10.1098/rstb.2006.1939 CrossRefPubMedPubMedCentral

Hebben N, Milberg W (2009) Essentials of neuropsychological assessment. Wiley, New York

Hoekstra JA, van Lieburg AF, Monnens LA et al (1996) Cognitive and psychosocial functioning of patients with congenital nephrogenic diabetes insipidus. Am J Med Genet 61:81–88. https://doi.org/10.1002/(SICI)1096-8628(19960102)61:1%3c81:AID-AJMG17%3e3.0.CO;2-S CrossRefPubMed

Johnson ZV, Young LJ (2017) Oxytocin and vasopressin neural networks: implications for social behavioral diversity and translational neuroscience. Neurosci Biobehav Rev 76:87–98. https://doi.org/10.1016/j.neubiorev.2017.01.034 CrossRefPubMedPubMedCentral

Kaplan RM, Saccuzzo DP (2013) Psychological testing: principles, applications, & issues, 8th edn. Wadsworth, Cengage Learning, Belmont

Klein RG, Mannuzza S, Olazagasti MAR et al (2012) Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later. Arch Gen Psychiatry 69:1295. https://doi.org/10.1001/archgenpsychiatry.2012.271 CrossRefPubMedPubMedCentral

Laczi F, László FA, Kovács GL et al (1987) Differential effect of desglycinamide9-(Arg8)-vasopressin on cognitive functions of diabetes insipidus and alcoholic patients. Acta Endocrinol (Copenh) 115:392–398CrossRef

Langley K, Fowler T, Ford T et al (2010) Adolescent clinical outcomes for young people with attention-deficit hyperactivity disorder. Br J Psychiatry 196:235–240. https://doi.org/10.1192/bjp.bp.109.066274 CrossRefPubMed

Loe IM, Feldman HM (2007) Academic and educational outcomes of children with ADHD. Ambul Pediatr Off J Ambul Pediatr Assoc 7:82–90. https://doi.org/10.1016/j.ambp.2006.05.005 CrossRef

Madras BK, Miller GM, Fischman AJ (2005) The dopamine transporter and attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1397–1409. https://doi.org/10.1016/j.biopsych.2004.10.011 CrossRefPubMed

Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M (2011) Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci 12:524–538. https://doi.org/10.1038/nrn3044 CrossRef

Mick E, Faraone SV (2008) Genetics of attention deficit hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 17:261–284. https://doi.org/10.1016/j.chc.2007.11.011 CrossRefPubMed

Nabe K, Honjo S, Ikeda H et al (2007) Diabetes insipidus and cognitive function. Med Hypotheses 69:764–766. https://doi.org/10.1016/j.mehy.2007.01.081 CrossRefPubMed

Porter RS, Kaplan JL, Merck & Co (2011) The Merck manual of diagnosis and therapy. Merck Sharp & Dohme Corp., Whitehouse Station

Raggenbass M (2008) Overview of cellular electrophysiological actions of vasopressin. Eur J Pharmacol 583:243–254. https://doi.org/10.1016/j.ejphar.2007.11.074 CrossRefPubMed

Rittig S, Robertson GL, Siggaard C et al (1996) Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus. Am J Hum Genet 58:107–117PubMedPubMedCentral

Skuse DH, Gallagher L (2011) Genetic influences on social cognition. Pediatr Res 69:85R–91R. https://doi.org/10.1203/PDR.0b013e318212f562 CrossRefPubMed

Swanson JM, Sunohara GA, Kennedy JL et al (1998) Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach. Mol Psychiatry 3:38–41. https://doi.org/10.1038/sj.mp.4000354 CrossRefPubMed

Thapar A, Cooper M (2015) Attention deficit hyperactivity disorder. Lancet. https://doi.org/10.1016/S0140-6736(15)00238-X CrossRefPubMed

Van West D, Del-Favero J, Deboutte D et al (2009) Arginine vasopressin receptor gene-based single-nucleotide polymorphism analysis in attention deficit hyperactivity disorder. Psychiatr Genet 19:102–103. https://doi.org/10.1097/YPG.0b013e32832a0b2b CrossRefPubMed

Volkow ND, Wang G-J, Kollins SH et al (2009) Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA 302:1084–1091. https://doi.org/10.1001/jama.2009.1308 CrossRefPubMedPubMedCentral

World Health Organization (ed) (1992) The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization, Geneva

Title: ADHD symptoms in a young patient with central diabetes insipidus
Authors: Irene Dupong
Sophie Guilmin-Crepon
Peyre Hugo
Publication date: 01-12-2018
Publisher: Springer Vienna
Published in: ADHD Attention Deficit and Hyperactivity Disorders / Issue 4/2018
Print ISSN: 1866-6116
Electronic ISSN: 1866-6647
DOI: https://doi.org/10.1007/s12402-018-0264-y

At a glance: The STEP trials

Springer Medicine

ADHD symptoms in a young patient with central diabetes insipidus

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2018

Evaluating attention-deficit/hyperactivity disorder using ecological momentary assessment: a systematic review

What stops practitioners discussing medication breaks in children and adolescents with ADHD? Identifying barriers through theory-driven qualitative research

Parent and child neurocognitive functioning predict response to behavioral parent training for youth with ADHD

Editors must be vigilant to guarantee the quality and credibility of published scientific work

How do children with and without ADHD talk about frustration?: Use of a novel emotion narrative recall task

Hyperactivity in mice lacking one allele of the glutamic acid decarboxylase 67 gene